Volume 96 Issue 10 | p. 11 | Concentrates
Issue Date: March 5, 2018

BASF debuts omega-3 medical food

Department: Business
Keywords: Pharmaceuticals, BASF, medical food
[+]Enlarge
Credit: BASF
BASF's new medical food.
 
Credit: BASF

BASF is entering the medical food market with the launch of a product for people with nonalcoholic fatty liver disease (NAFLD). Hepaxa, a pill containing highly concentrated and pure omega-3 acids—eicosapentaenoic and docosahexaenoic acids—is being called the first product in the U.S. designed to address a buildup of fat in the liver, known as steatosis, in people with NAFLD. Diem Labs will distribute it. The two firms announced an agreement last year to work together in the medical food arena.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment